Handelsavisen
prelaunch
Companies Financials WWH.L
WW
WWH.L London Stock Exchange UK Investment Trusts

Worldwide Healthcare Trust PLC

$373,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,71 %
Op margin
112,7 %
ROE
-12,5 %
Net margin
113,1 %
Debt / equity
0,04
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.

Business. Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.

Classification92 %
SectorFinancials
Business sectorCollective Investments
IndustryUK Investment Trusts
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-12,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning WWH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to WWH.L. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Worldwide Healthcare Trust PLC is a UK-based investment trust that focuses on healthcare-related assets, generating returns primarily through capital appreciation and income from its investment portfolio.

    Classification92 %
    SectorFinancials
    Business sectorCollective Investments
    IndustryUK Investment Trusts
    AI synthesis
    GENERATED

    Worldwide Healthcare Trust PLC exhibits a capital structure with a low debt-to-equity ratio of 0.04, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.04, suggesting it has limited short-term liquidity cushion. The negative operating cash flow of -1.54 million GBP raises concerns about its ability to fund operations without external financing.

    Profitability metrics are severely negative, with a return on equity of -12.49% and a return on assets of -11.81%. These figures are well below the typical performance of UK investment trusts, which usually aim for positive returns through effective portfolio management. The company's net income of -209.77 million GBP and operating income of -209.17 million GBP further underscore its financial distress.

    The company's revenue is entirely derived from its investment portfolio, with no disclosed geographic or segment diversification. The negative revenue of -185.53 million GBP indicates a decline in the value of its investments or a reduction in income from its portfolio. There is no indication of geographic diversification, and the company's exposure is likely concentrated in the UK healthcare sector.

    The company's growth trajectory is negative, with a substantial decline in revenue and profitability. The outlook for the current fiscal year is not provided, but the historical performance suggests a challenging environment. The company's operating cash flow and net income figures indicate a deteriorating financial position, with no clear signs of recovery in the near term.

    Risk factors include medium liquidity risk and low dilution potential. The company's net cash is negative after subtracting total debt, which increases its vulnerability to short-term financial stress. The low dilution potential suggests that the company is not likely to issue additional shares in the near term, which could be a positive sign for existing shareholders.

    Recent events include a significant decline in the company's financial performance, as reflected in its negative operating and net income. There are no recent filings or transcripts indicating strategic changes or new initiatives that could reverse the company's financial trajectory. The ESG scores suggest moderate social performance but weak governance, with a high ESG controversies score indicating potential reputational risks.

    Key takeaways
    • The company is experiencing significant financial distress, with negative net income and operating income.
    • The low debt-to-equity ratio suggests a conservative capital structure, but the negative operating cash flow raises liquidity concerns.
    • The company's performance is well below the typical returns expected from UK investment trusts.
    • The ESG scores indicate moderate social performance but weak governance and high controversy risk.
    • There is no indication of geographic or segment diversification, and the company's exposure is likely concentrated in the UK healthcare sector.
    • The company is unlikely to issue additional shares in the near term, which could be a positive sign for existing shareholders.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $373,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.68B
    Net cash
    -$68.1M
    Current ratio
    1.0
    Debt / equity
    0.0
    ROA
    -11.8%
    ROE
    -12.5%
    Cash conversion
    1.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin112,7 %Above P75
    Net Margin113,1 %Above P75
    ROE-12,5 %Bottom quartile
    D/E0,04Above median
    Cash Conv0,01Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Worldwide Healthcare Trust PLC Market data — financials · 2026-05-30
    • Worldwide Healthcare Trust PLC Market data — ESG · 2026-05-30

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    WWH.LCanonical
    London Stock Exchange · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage